Corcept Therapeutics reported 630K in Interest Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Income Change
Acadia Pharmaceuticals ACAD:US 580K 475K
Aurora Cannabis Inc ACB:CN 660K 275K
BioMarin Pharmaceutical BMRN:US 2.5M 685K
Corcept Therapeutics CORT:US 630K 550K
Eli Lilly LLY:US 10.2M 3.2M
Esperion Therapeutics ESPR:US 400K 100K
Knight Therapeutics Inc GUD:CN 708K 362K
Nektar Therapeutics NKTR:US 1.1M 701K
Pacira PCRX:US 252K 19K
Pfizer PFE:US 30M 16M
Supernus Pharmaceuticals SUPN:US 1.79M 12.91M